By Eric Sagonowsky
With numerous COVID-19 vaccines in late-stage testing, the FDA may soon face critical decisions on whether the candidates are safe and effective enough for emergency use or widespread distribution. While the agency has come under political pressure during the pandemic, commissioner Stephen Hahn on Monday stressed its procedures are adequate to maintain independence for the forthcoming reviews.
read more
By Robert King
Hospitals have had to more closely scrutinize their PPE vendors and suppliers to ensure there are no disruptions in the supply chain, a practice that will likely continue after COVID-19 ends.
read more
By Conor Hale
Quidel snagged an FDA emergency authorization for what it describes as a rapid “ABC” test—a 15-minute, point-of-care diagnostic for influenza A, influenza B and COVID-19—as experts raise alarms about a potential "twindemic" this winter. It's the latest pandemic move for Quidel, which tripled third-quarter sales thanks to its Sofia-2 antigen test.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
Trump's dexamethasone regimen has sparked concerns over the President's health. Regeneron's decision to provide its experimental antibody to the President was difficult, its CEO said; plus, Regeneron's cocktail now faces a patent suit from Allele Biotechnology. The NIH will spend $234 million to improve testing access. Plus, Quidel won approval for a combo flu-COVID-19 test.
read more
By Robert King
Hospital system CommonSpirit Health reported operating losses of $550 million during its fiscal year that ended in June, as the COVID-19 pandemic continues to roil patient volumes.
read more
By Conor Hale
Through its COVID-19 diagnostic development initiative, the NIH announced it has awarded nearly $234 million to improve access to testing among underserved and vulnerable populations.
read more
By Conor Hale
Through a new partnership with GlaxoSmithKline, AstraZeneca and the U.K.’s National Health Service, the chip maker Nvidia plans to build Great Britain’s most powerful supercomputer—and dedicate it to artificial intelligence research in healthcare.
read more
By Paige Minemyer
With employer open enrollment on the horizon, these are the key trends to watch, according to the Business Group on Health.
read more
